DE3751218D1 - Verfahren und therapeutische Zubereitungen für die Behandlung von Gerinnungsstörungen. - Google Patents

Verfahren und therapeutische Zubereitungen für die Behandlung von Gerinnungsstörungen.

Info

Publication number
DE3751218D1
DE3751218D1 DE3751218T DE3751218T DE3751218D1 DE 3751218 D1 DE3751218 D1 DE 3751218D1 DE 3751218 T DE3751218 T DE 3751218T DE 3751218 T DE3751218 T DE 3751218T DE 3751218 D1 DE3751218 D1 DE 3751218D1
Authority
DE
Germany
Prior art keywords
treatment
methods
coagulation disorders
therapeutic preparations
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3751218T
Other languages
English (en)
Other versions
DE3751218T2 (de
Inventor
Donogh Paul O'brien
Gordon Allen Vehar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25453974&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3751218(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE3751218D1 publication Critical patent/DE3751218D1/de
Application granted granted Critical
Publication of DE3751218T2 publication Critical patent/DE3751218T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE3751218T 1986-11-04 1987-11-02 Verfahren und therapeutische Zubereitungen für die Behandlung von Gerinnungsstörungen. Expired - Lifetime DE3751218T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92697786A 1986-11-04 1986-11-04

Publications (2)

Publication Number Publication Date
DE3751218D1 true DE3751218D1 (de) 1995-05-11
DE3751218T2 DE3751218T2 (de) 1995-11-09

Family

ID=25453974

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3751218T Expired - Lifetime DE3751218T2 (de) 1986-11-04 1987-11-02 Verfahren und therapeutische Zubereitungen für die Behandlung von Gerinnungsstörungen.

Country Status (8)

Country Link
EP (1) EP0266993B1 (de)
JP (1) JP2758162B2 (de)
AT (1) ATE120645T1 (de)
CA (1) CA1317878C (de)
DE (1) DE3751218T2 (de)
ES (1) ES2073391T3 (de)
NZ (1) NZ222434A (de)
ZA (1) ZA878249B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589173A (en) 1986-11-04 1996-12-31 Genentech, Inc. Method and therapeutic compositions for the treatment of myocardial infarction
AU631603B2 (en) * 1989-02-02 1992-12-03 Teijin Limited Detection of human tissue factor activator
US6749853B1 (en) 1992-03-05 2004-06-15 Board Of Regents, The University Of Texas System Combined methods and compositions for coagulation and tumor treatment
KR100565883B1 (ko) 1997-01-22 2006-03-31 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 응고 및 종양 치료용 조직 인자 방법 및 조성물
ES2188202T3 (es) 1998-07-13 2003-06-16 Univ Texas Metodos de tratamiento para el cancer usando conjugados terapeuticos que se enlazan con aminofosfolipidos.
US6818213B1 (en) 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
WO2000004148A1 (en) 1998-07-15 2000-01-27 Genentech, Inc. Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia
US6703494B2 (en) 2000-03-16 2004-03-09 Genentech, Inc. Anti-tissue factor antibodies with enhanced anticoagulant potency
US7772371B2 (en) 2005-08-03 2010-08-10 Thrombotargets Corporation Stimulators of Factor X activated (FXa) as new topical antihemorrhagic agents
EP1749536A1 (de) * 2005-08-03 2007-02-07 Thrombotargets Europe, S.L. Aktivierte Stimulatoren des Faktors X als antihämorrhagisches Mittel für die topische Anwendung
WO2016150449A1 (en) * 2015-03-23 2016-09-29 Dana Genetic A/S Recombinant soluble human tissue factor, method of its production and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL64879C (de) * 1944-05-20
DE3150596A1 (de) * 1981-12-21 1983-06-30 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von gewebsthromboplastin

Also Published As

Publication number Publication date
CA1317878C (en) 1993-05-18
EP0266993A3 (en) 1988-07-27
JP2758162B2 (ja) 1998-05-28
DE3751218T2 (de) 1995-11-09
ATE120645T1 (de) 1995-04-15
EP0266993B1 (de) 1995-04-05
ES2073391T3 (es) 1995-08-16
EP0266993A2 (de) 1988-05-11
JPS63218625A (ja) 1988-09-12
NZ222434A (en) 1990-06-26
ZA878249B (en) 1989-07-26

Similar Documents

Publication Publication Date Title
ATE198712T1 (de) Verfahren und zusammensetzungen für die spezifische koagulation von tumorgefässen
DE68919361T2 (de) Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
DE69200675T2 (de) Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen.
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
ATE235907T1 (de) Verwendung von kompetitiven progesteronantagonisten für die herstellung von arzneimitteln zur behandlung von dysfunktionellen uterinen blutungen
ATE120645T1 (de) Verfahren und therapeutische zubereitungen für die behandlung von gerinnungsstörungen.
DE68921413D1 (de) Verbindungen und Zusammensetzungen zur Anwendung bei Methoden zur Behandlung und Prophylaxe von Pneumocystis Carinii Pneumonia und anderen Krankheiten.
NO913129D0 (no) Nytt trombolytisk middel.
DE69110713T2 (de) 7-Oxabicycloheptan-imidazol-prostaglandin-Analoge, verwendbar bei der Behandlung von thrombotischen und vasospastischen Erkrankungen.
DE69007486T2 (de) Verwendung von calciumantagonisten für die behandlung von narben.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
DE68908445T2 (de) Mittel zur Behandlung von Lebererkrankungen.
DE68914886T2 (de) Mittel zur Behandlung von Raynaud's Krankheit.
ATE91886T1 (de) Praeparat zur behandlung von erektionsstoerungen.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
DE68905479D1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.
ATE95061T1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.